Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans
- PMID: 10698877
- PMCID: PMC27301
- DOI: 10.1136/bmj.320.7235.606
Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans
Abstract
Objective: To assess the effectiveness of antenatal screening for Down's syndrome by maternal age and routine mid-pregnancy ultrasound scanning.
Design: Retrospective six year survey.
Setting: Maternity units of a district general hospital.
Subjects: Pregnant women booked for delivery in hospital between 1 January 1993 and 31 December 1998.
Main outcome measures: All cases of Down's syndrome occurring in district identified from regional congenital anomaly register and cytogenetic laboratory records. Women's case notes were examined to identify indication for karyotyping, gestation at diagnosis, and outcome of pregnancy.
Results: 31 259 deliveries occurred during study period, and 57 cases of Down's syndrome were identified, four in failed pregnancies and 53 in ongoing pregnancies or in neonates. The analysis was confined to ongoing pregnancies or liveborn children. Invasive antenatal tests were performed in 6.6% (2053/31 259), and 68% (95% confidence interval 56% to 80%) of cases of Down's syndrome were detected antenatally, giving a positive predictive value of 1.8%. There were 17 undetected cases, and in seven of these the women had declined an offer of invasive testing. In women aged less than 35 years the detection rate was 53% (30% to 76%). Most of the cases detected in younger women followed identification of ultrasound anomalies.
Conclusions: The overall detection rate was considerably higher than assumed in demonstration projects for serum screening. As a result, the benefits of serum screening are much less than supposed. Before any new methods to identify Down's syndrome are introduced, such as nuchal translucency or first trimester serum screening, the techniques should be tested in properly controlled trials.
Comment in
-
Evidence based screening for Down's syndrome. We should be prepared to re-examine entrenched practices.BMJ. 2000 Mar 4;320(7235):592-3. doi: 10.1136/bmj.320.7235.592. BMJ. 2000. PMID: 10698857 Free PMC article. No abstract available.
-
Screening for Down's syndrome. Biochemical screening offers advantages.BMJ. 2000 Sep 23;321(7263):762; author reply 764-5. BMJ. 2000. PMID: 10999923 Free PMC article. No abstract available.
-
Screening for Down's syndrome. Serum screening shows a clear benefit across age groups.BMJ. 2000 Sep 23;321(7263):762-3; author reply 764-5. BMJ. 2000. PMID: 10999924 No abstract available.
-
Screening for Down's syndrome. Data do not support study's claim.BMJ. 2000 Sep 23;321(7263):763; author reply 764-5. BMJ. 2000. PMID: 10999925 No abstract available.
-
Screening for Down's syndrome. Statistical modelling is best tool for formulating screening policy.BMJ. 2000 Sep 23;321(7263):763; author reply 764-5. BMJ. 2000. PMID: 10999926 No abstract available.
-
Screening for Down's syndrome. Serum screening programmes are effective and safe.BMJ. 2000 Sep 23;321(7263):763-4; author reply 764-5. BMJ. 2000. PMID: 10999927 No abstract available.
-
Screening for Down's syndrome. A large independent trial would be useful.BMJ. 2000 Sep 23;321(7263):764-5. BMJ. 2000. PMID: 10999928 No abstract available.
Similar articles
-
Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in one health region.BMJ. 2002 Jul 6;325(7354):15. doi: 10.1136/bmj.325.7354.15. BMJ. 2002. PMID: 12098722 Free PMC article.
-
Importance of the integrated test in the Down's syndrome screening algorithm.J Med Screen. 2018 Sep;25(3):114-118. doi: 10.1177/0969141317752533. Epub 2018 Mar 25. J Med Screen. 2018. PMID: 29575979
-
SURUSS in perspective.BJOG. 2004 Jun;111(6):521-31. doi: 10.1111/j.1471-0528.2004.00193.x. BJOG. 2004. PMID: 15198778
-
Antenatal screening for Down's syndrome.J Med Screen. 1997;4(4):181-246. doi: 10.1177/096914139700400402. J Med Screen. 1997. PMID: 9494915 Review.
-
Down's syndrome screening in pregnancies after assisted reproductive techniques: an update.Reprod Biomed Online. 2002 May-Jun;4(3):285-93. doi: 10.1016/s1472-6483(10)61819-6. Reprod Biomed Online. 2002. PMID: 12709282 Review.
Cited by
-
Evidence based screening for Down's syndrome. We should be prepared to re-examine entrenched practices.BMJ. 2000 Mar 4;320(7235):592-3. doi: 10.1136/bmj.320.7235.592. BMJ. 2000. PMID: 10698857 Free PMC article. No abstract available.
-
First trimester serum tests for Down's syndrome screening.Cochrane Database Syst Rev. 2015 Nov 30;2015(11):CD011975. doi: 10.1002/14651858.CD011975. Cochrane Database Syst Rev. 2015. PMID: 26617074 Free PMC article.
-
Screening for Down's syndrome. Antenatal screening has human costs.BMJ. 2002 Jan 12;324(7329):110. BMJ. 2002. PMID: 11786462 Free PMC article. No abstract available.
-
Second trimester serum tests for Down's Syndrome screening.Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD009925. doi: 10.1002/14651858.CD009925. Cochrane Database Syst Rev. 2012. PMID: 22696388 Free PMC article.
-
Screening for Down's syndrome. Biochemical screening offers advantages.BMJ. 2000 Sep 23;321(7263):762; author reply 764-5. BMJ. 2000. PMID: 10999923 Free PMC article. No abstract available.
References
-
- Royal College of Obstetricians and Gynaecologists. Report of the working party on biochemical markers and the detection of Down's syndrome. London: RCOG Press; 1993.
-
- Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med. 1992;327:588–593. - PubMed
-
- Cheng E, Luthy D, Zebelman A, Williams M, Lieppman R, Hickok D. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Obstet Gynecol. 1993;81:72–77. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials